Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

ADMA – Adma Biologics Inc

ADMA Biologics Inc
ADMA
$20.50
Name : ADMA Biologics Inc
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $4,894,047,232.00
EPSttm : 0.84
finviz dynamic chart for ADMA
ADMA Biologics Inc
$20.50
2.81%
$0.56

Float Short %

5.79

Margin Of Safety %

41

Put/Call OI Ratio

0.53

EPS Next Q Diff

0.06

EPS Last/This Y

-0.25

EPS This/Next Y

0.35

Price

19.94

Target Price

32.33

Analyst Recom

1.5

Performance Q

17.92

Relative Volume

0.44

Beta

0.47

Ticker: ADMA




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-05-07ADMA23.610.651.1295047
2025-05-08ADMA21.20.701.87101694
2025-05-09ADMA19.980.700.79106766
2025-05-12ADMA20.450.680.83109239
2025-05-13ADMA19.880.680.17109207
2025-05-14ADMA19.450.590.30109832
2025-05-15ADMA19.190.570.47110507
2025-05-16ADMA19.770.561.13111030
2025-05-19ADMA20.210.530.1285315
2025-05-20ADMA20.440.520.4186571
2025-05-21ADMA20.120.520.2186976
2025-05-22ADMA20.160.520.5287265
2025-05-23ADMA20.420.521.2687700
2025-05-27ADMA19.850.530.5588108
2025-05-28ADMA19.50.540.6088430
2025-05-29ADMA19.780.544.0288502
2025-05-30ADMA19.830.510.4787278
2025-06-02ADMA20.440.550.6989667
2025-06-03ADMA20.470.560.2988448
2025-06-04ADMA20.330.563.8988501
2025-06-05ADMA19.940.530.8786966
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-05-07ADMA23.61- - 0.66
2025-05-08ADMA21.19- - 0.66
2025-05-09ADMA19.98- - 0.66
2025-05-12ADMA20.45- - 0.66
2025-05-13ADMA19.867.7- 0.64
2025-05-14ADMA19.45- - 0.66
2025-05-15ADMA19.197.7- 0.66
2025-05-16ADMA19.707.7- 0.60
2025-05-19ADMA20.197.7- 0.60
2025-05-20ADMA20.457.7- 0.60
2025-05-21ADMA20.127.7- 0.60
2025-05-22ADMA20.177.7- 0.60
2025-05-23ADMA20.427.7- 0.60
2025-05-27ADMA19.897.7- 0.60
2025-05-28ADMA19.517.7- 0.60
2025-05-29ADMA19.757.7- 0.60
2025-05-30ADMA19.847.7- 0.60
2025-06-02ADMA20.437.7- 0.60
2025-06-03ADMA20.467.7- 0.60
2025-06-04ADMA20.327.7- 0.60
2025-06-05ADMA19.947.7- 0.60
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-05-07ADMA-1.26-3.445.76
2025-05-08ADMA-1.26-3.445.76
2025-05-09ADMA-1.26-3.445.76
2025-05-12ADMA-1.26-4.025.36
2025-05-13ADMA-1.26-4.025.36
2025-05-14ADMA-1.26-4.025.36
2025-05-15ADMA-1.26-4.025.36
2025-05-16ADMA-1.26-4.025.36
2025-05-19ADMA-1.50-4.665.36
2025-05-20ADMA-1.50-4.665.36
2025-05-21ADMA-1.50-4.665.36
2025-05-22ADMA-1.50-4.665.36
2025-05-23ADMA-0.75-4.665.36
2025-05-27ADMA-0.86-1.755.36
2025-05-28ADMA-0.86-1.755.79
2025-05-29ADMA-0.86-1.755.79
2025-05-30ADMA-0.86-1.755.79
2025-06-02ADMA-0.86-0.025.79
2025-06-03ADMA-0.86-0.025.79
2025-06-04ADMA-0.86-0.025.79
2025-06-05ADMA-0.86-0.025.79
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

0.11

Avg. EPS Est. Current Quarter

0.14

Avg. EPS Est. Next Quarter

0.17

Insider Transactions

-0.86

Institutional Transactions

-0.02

Beta

0.47

Average Sales Estimate Current Quarter

124

Average Sales Estimate Next Quarter

133

Fair Value

28.13

Quality Score

99

Growth Score

76

Sentiment Score

95

Actual DrawDown %

22.3

Max Drawdown 5-Year %

-70.9

Target Price

32.33

P/E

23.62

Forward P/E

20.28

PEG

0.58

P/S

10.36

P/B

12.74

P/Free Cash Flow

52.52

EPS

0.84

Average EPS Est. Cur. Y​

0.6

EPS Next Y. (Est.)

0.95

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

45.01

Relative Volume

0.44

Return on Equity vs Sector %

31.4

Return on Equity vs Industry %

49.2

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.1

EBIT Estimation

ADMA Biologics Inc
Sector: Healthcare
Industry: Biotechnology
Employees: 685
ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, a human polyclonal antibody product for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics comprising products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.
stock quote shares ADMA – Adma Biologics Inc Stock Price stock today
news today ADMA – Adma Biologics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch ADMA – Adma Biologics Inc yahoo finance google finance
stock history ADMA – Adma Biologics Inc invest stock market
stock prices ADMA premarket after hours
ticker ADMA fair value insiders trading